Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 2000 Nov;79(5):2305–2313. doi: 10.1016/S0006-3495(00)76476-9

Function-related regulation of the stability of MHC proteins.

A Simon 1, Z s Dosztányi 1, E Rajnavölgyi 1, I Simon 1
PMCID: PMC1301118  PMID: 11053110

Abstract

Proteins must be stable to accomplish their biological function and to avoid enzymatic degradation. Constitutive proteolysis, however, is the main source of free amino acids used for de novo protein synthesis. In this paper the delicate balance of protein stability and degradability is discussed in the context of function of major histocompatibility complex (MHC) encoded protein. Classical MHC proteins are single-use peptide transporters that carry proteolytic degradation products to the cell surface for presenting them to T cells. These proteins fulfill their function as long as they bind their dissociable ligand, the peptide. Ligand-free MHC molecules on the cell surface are practically useless for their primary biological function, but may acquire novel activity or become an important source of amino acids when they lose their compact stable structure, which resists proteolytic attacks. We show in this paper that one or more of the stabilization centers responsible for the stability of MHC-peptide complexes is composed of residues of both the protein and the peptide, therefore missing in the ligand-free protein. This arrangement of stabilization centers provides a simple means of regulation; it makes the useful form of the protein stable, whereas the useless form of the same protein is unstable and therefore degradable.

Full Text

The Full Text of this article is available as a PDF (104.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arndt S. O., Vogt A. B., Markovic-Plese S., Martin R., Moldenhauer G., Wölpl A., Sun Y., Schadendorf D., Hämmerling G. J., Kropshofer H. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 2000 Mar 15;19(6):1241–1251. doi: 10.1093/emboj/19.6.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balendiran G. K., Solheim J. C., Young A. C., Hansen T. H., Nathenson S. G., Sacchettini J. C. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6880–6885. doi: 10.1073/pnas.94.13.6880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartnes K., Leon F., Briand J. P., Travers P. J., Hannestad K. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively. Eur J Immunol. 1999 Jan;29(1):189–195. doi: 10.1002/(SICI)1521-4141(199901)29:01<189::AID-IMMU189>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  4. Bouvier M., Wiley D. C. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer. Nat Struct Biol. 1998 May;5(5):377–384. doi: 10.1038/nsb0598-377. [DOI] [PubMed] [Google Scholar]
  5. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993 Jul 1;364(6432):33–39. doi: 10.1038/364033a0. [DOI] [PubMed] [Google Scholar]
  6. Busch R., Doebele R. C., Patil N. S., Pashine A., Mellins E. D. Accessory molecules for MHC class II peptide loading. Curr Opin Immunol. 2000 Feb;12(1):99–106. doi: 10.1016/s0952-7915(99)00057-6. [DOI] [PubMed] [Google Scholar]
  7. Ceman S., Wu S., Jardetzky T. S., Sant A. J. Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J Exp Med. 1998 Dec 7;188(11):2139–2149. doi: 10.1084/jem.188.11.2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins E. J., Garboczi D. N., Wiley D. C. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature. 1994 Oct 13;371(6498):626–629. doi: 10.1038/371626a0. [DOI] [PubMed] [Google Scholar]
  9. Dessen A., Lawrence C. M., Cupo S., Zaller D. M., Wiley D. C. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 1997 Oct;7(4):473–481. doi: 10.1016/s1074-7613(00)80369-6. [DOI] [PubMed] [Google Scholar]
  10. Dosztányi Z., Fiser A., Simon I. Stabilization centers in proteins: identification, characterization and predictions. J Mol Biol. 1997 Oct 3;272(4):597–612. doi: 10.1006/jmbi.1997.1242. [DOI] [PubMed] [Google Scholar]
  11. Edidin M., Achilles S., Zeff R., Wei T. Probing the stability of class I major histocompatibility complex (MHC) molecules on the surface of human cells. Immunogenetics. 1997;46(1):41–45. doi: 10.1007/s002510050240. [DOI] [PubMed] [Google Scholar]
  12. Fremont D. H., Hendrickson W. A., Marrack P., Kappler J. Structures of an MHC class II molecule with covalently bound single peptides. Science. 1996 May 17;272(5264):1001–1004. doi: 10.1126/science.272.5264.1001. [DOI] [PubMed] [Google Scholar]
  13. Fremont D. H., Matsumura M., Stura E. A., Peterson P. A., Wilson I. A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science. 1992 Aug 14;257(5072):919–927. doi: 10.1126/science.1323877. [DOI] [PubMed] [Google Scholar]
  14. Fremont D. H., Monnaie D., Nelson C. A., Hendrickson W. A., Unanue E. R. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity. 1998 Mar;8(3):305–317. doi: 10.1016/s1074-7613(00)80536-1. [DOI] [PubMed] [Google Scholar]
  15. Fremont D. H., Stura E. A., Matsumura M., Peterson P. A., Wilson I. A. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2479–2483. doi: 10.1073/pnas.92.7.2479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Garcia K. C., Teyton L. T-cell receptor peptide-MHC interactions: biological lessons from structural studies. Curr Opin Biotechnol. 1998 Aug;9(4):338–343. doi: 10.1016/s0958-1669(98)80004-9. [DOI] [PubMed] [Google Scholar]
  17. Germain R. N. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. Semin Immunol. 1995 Dec;7(6):361–372. doi: 10.1006/smim.1995.0041. [DOI] [PubMed] [Google Scholar]
  18. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 1993;11:403–450. doi: 10.1146/annurev.iy.11.040193.002155. [DOI] [PubMed] [Google Scholar]
  19. Germain R. N., Rinker A. G., Jr Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature. 1993 Jun 24;363(6431):725–728. doi: 10.1038/363725a0. [DOI] [PubMed] [Google Scholar]
  20. Ghosh P., Amaya M., Mellins E., Wiley D. C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 1995 Nov 30;378(6556):457–462. doi: 10.1038/378457a0. [DOI] [PubMed] [Google Scholar]
  21. Glithero A., Tormo J., Haurum J. S., Arsequell G., Valencia G., Edwards J., Springer S., Townsend A., Pao Y. L., Wormald M. Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity. 1999 Jan;10(1):63–74. doi: 10.1016/s1074-7613(00)80007-2. [DOI] [PubMed] [Google Scholar]
  22. Gogolák P., Simon A., Horváth A., Réthi B., Simon I., Berkics K., Rajnavölgyi E., Tóth G. K. Mapping of a protective helper T cell epitope of human influenza A virus hemagglutinin. Biochem Biophys Res Commun. 2000 Apr 2;270(1):190–198. doi: 10.1006/bbrc.2000.2384. [DOI] [PubMed] [Google Scholar]
  23. Hansen T., Balendiran G., Solheim J., Ostrov D., Nathenson S. Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. Immunol Today. 2000 Feb;21(2):83–88. doi: 10.1016/s0167-5699(98)01426-1. [DOI] [PubMed] [Google Scholar]
  24. Harding C. V., Geuze H. J. Antigen processing and intracellular traffic of antigens and MHC molecules. Curr Opin Cell Biol. 1993 Aug;5(4):596–605. doi: 10.1016/0955-0674(93)90128-d. [DOI] [PubMed] [Google Scholar]
  25. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):734–738. doi: 10.1073/pnas.93.2.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jondal M., Schirmbeck R., Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity. 1996 Oct;5(4):295–302. doi: 10.1016/s1074-7613(00)80255-1. [DOI] [PubMed] [Google Scholar]
  27. Khare S. D., Hansen J., Luthra H. S., David C. S. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996 Dec 15;98(12):2746–2755. doi: 10.1172/JCI119100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koopmann J. O., Hämmerling G. J., Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol. 1997 Feb;9(1):80–88. doi: 10.1016/s0952-7915(97)80163-x. [DOI] [PubMed] [Google Scholar]
  29. Lanzavecchia A., Reid P. A., Watts C. Irreversible association of peptides with class II MHC molecules in living cells. Nature. 1992 May 21;357(6375):249–252. doi: 10.1038/357249a0. [DOI] [PubMed] [Google Scholar]
  30. Li H., Natarajan K., Malchiodi E. L., Margulies D. H., Mariuzza R. A. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J Mol Biol. 1998;283(1):179–191. doi: 10.1006/jmbi.1998.2091. [DOI] [PubMed] [Google Scholar]
  31. Ljunggren H. G., Stam N. J., Ohlén C., Neefjes J. J., Höglund P., Heemels M. T., Bastin J., Schumacher T. N., Townsend A., Kärre K. Empty MHC class I molecules come out in the cold. Nature. 1990 Aug 2;346(6283):476–480. doi: 10.1038/346476a0. [DOI] [PubMed] [Google Scholar]
  32. Madden D. R., Garboczi D. N., Wiley D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 1993 Nov 19;75(4):693–708. doi: 10.1016/0092-8674(93)90490-h. [DOI] [PubMed] [Google Scholar]
  33. Madden D. R., Gorga J. C., Strominger J. L., Wiley D. C. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature. 1991 Sep 26;353(6342):321–325. doi: 10.1038/353321a0. [DOI] [PubMed] [Google Scholar]
  34. Madden D. R. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol. 1995;13:587–622. doi: 10.1146/annurev.iy.13.040195.003103. [DOI] [PubMed] [Google Scholar]
  35. Maenaka K., Jones E. Y. MHC superfamily structure and the immune system. Curr Opin Struct Biol. 1999 Dec;9(6):745–753. doi: 10.1016/s0959-440x(99)00039-1. [DOI] [PubMed] [Google Scholar]
  36. Matko J., Bushkin Y., Wei T., Edidin M. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J Immunol. 1994 Apr 1;152(7):3353–3360. [PubMed] [Google Scholar]
  37. McFarland B. J., Beeson C., Sant A. J. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J Immunol. 1999 Oct 1;163(7):3567–3571. [PubMed] [Google Scholar]
  38. Menssen R., Orth P., Ziegler A., Saenger W. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J Mol Biol. 1999 Jan 15;285(2):645–653. doi: 10.1006/jmbi.1998.2363. [DOI] [PubMed] [Google Scholar]
  39. Micheletti F., Bazzaro M., Canella A., Marastoni M., Traniello S., Gavioli R. The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses. Immunology. 1999 Mar;96(3):411–415. doi: 10.1046/j.1365-2567.1999.00707.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Murthy V. L., Stern L. J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure. 1997 Oct 15;5(10):1385–1396. doi: 10.1016/s0969-2126(97)00288-8. [DOI] [PubMed] [Google Scholar]
  41. Rabinowitz J. D., Vrljic M., Kasson P. M., Liang M. N., Busch R., Boniface J. J., Davis M. M., McConnell H. M. Formation of a highly peptide-receptive state of class II MHC. Immunity. 1998 Nov;9(5):699–709. doi: 10.1016/s1074-7613(00)80667-6. [DOI] [PubMed] [Google Scholar]
  42. Rajnavölgyi E., Horváth A., Gogolák P., Tóth G. K., Fazekas G., Fridkin M., Pecht I. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Eur J Immunol. 1997 Dec;27(12):3105–3114. doi: 10.1002/eji.1830271205. [DOI] [PubMed] [Google Scholar]
  43. Rammensee H. G. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol. 1995 Feb;7(1):85–96. doi: 10.1016/0952-7915(95)80033-6. [DOI] [PubMed] [Google Scholar]
  44. Rammensee H. G., Friede T., Stevanoviíc S. MHC ligands and peptide motifs: first listing. Immunogenetics. 1995;41(4):178–228. doi: 10.1007/BF00172063. [DOI] [PubMed] [Google Scholar]
  45. Reich Z., Altman J. D., Boniface J. J., Lyons D. S., Kozono H., Ogg G., Morgan C., Davis M. M. Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2495–2500. doi: 10.1073/pnas.94.6.2495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Reid S. W., McAdam S., Smith K. J., Klenerman P., O'Callaghan C. A., Harlos K., Jakobsen B. K., McMichael A. J., Bell J. I., Stuart D. I. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med. 1996 Dec 1;184(6):2279–2286. doi: 10.1084/jem.184.6.2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Santambrogio L., Sato A. K., Fischer F. R., Dorf M. E., Stern L. J. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15050–15055. doi: 10.1073/pnas.96.26.15050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sato A. K., Sturniolo T., Sinigaglia F., Stern L. J. Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303). Hum Immunol. 1999 Dec;60(12):1227–1236. doi: 10.1016/s0198-8859(99)00120-2. [DOI] [PubMed] [Google Scholar]
  49. Schafer P. H., Malapati S., Hanfelt K. K., Pierce S. K. The assembly and stability of MHC class II-(alpha beta)2 superdimers. J Immunol. 1998 Sep 1;161(5):2307–2316. [PubMed] [Google Scholar]
  50. Scott C. A., Peterson P. A., Teyton L., Wilson I. A. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity. 1998 Mar;8(3):319–329. doi: 10.1016/s1074-7613(00)80537-3. [DOI] [PubMed] [Google Scholar]
  51. Smith K. J., Pyrdol J., Gauthier L., Wiley D. C., Wucherpfennig K. W. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med. 1998 Oct 19;188(8):1511–1520. doi: 10.1084/jem.188.8.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Smith K. J., Reid S. W., Harlos K., McMichael A. J., Stuart D. I., Bell J. I., Jones E. Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity. 1996 Mar;4(3):215–228. doi: 10.1016/s1074-7613(00)80430-6. [DOI] [PubMed] [Google Scholar]
  53. Smith K. J., Reid S. W., Stuart D. I., McMichael A. J., Jones E. Y., Bell J. I. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity. 1996 Mar;4(3):203–213. doi: 10.1016/s1074-7613(00)80429-x. [DOI] [PubMed] [Google Scholar]
  54. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994 Mar 17;368(6468):215–221. doi: 10.1038/368215a0. [DOI] [PubMed] [Google Scholar]
  55. Stern L. J., Wiley D. C. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell. 1992 Feb 7;68(3):465–477. doi: 10.1016/0092-8674(92)90184-e. [DOI] [PubMed] [Google Scholar]
  56. Willcox B. E., Gao G. F., Wyer J. R., Ladbury J. E., Bell J. I., Jakobsen B. K., van der Merwe P. A. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 1999 Mar;10(3):357–365. doi: 10.1016/s1074-7613(00)80035-7. [DOI] [PubMed] [Google Scholar]
  57. Young A. C., Zhang W., Sacchettini J. C., Nathenson S. G. The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection. Cell. 1994 Jan 14;76(1):39–50. doi: 10.1016/0092-8674(94)90171-6. [DOI] [PubMed] [Google Scholar]
  58. Zhao R., Loftus D. J., Appella E., Collins E. J. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J Exp Med. 1999 Jan 18;189(2):359–370. doi: 10.1084/jem.189.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES